Abstract:A potent drug candidature of two new copper (II) complexes have been synthesized and characterized by CHN analysis, FTIR, ESI‐MS and XRD techniques. The complexes have been analyzed biomolecular interactions by spectroscopic methods. Furthermore, radical scavenging and antiproliferative activities of the complexes were also investigated. [Cu(5‐ClSal‐Trp)(bpy)]·CH3OH (1) and [Cu(3,5‐ClSal‐Trp)(bpy)]·H2O (2) (5‐ClSal‐Trp: Schiff base derived from 5‐chlorosalicylaldehyde and tryptophan, 3,5‐ClSal‐Trp: Schiff base derived from 3,5‐dichlorosalicylaldehyde and tryptophan, bpy: 2,2′‐bipyridine) have been synthesized and analyzed by CHN analysis, FTIR, electronic absorption spectroscopy, ESI‐MS and XRD techniques. Interaction of the complexes with biomolecules {calf thymus DNA (CT‐DNA) and bovine serum albumin (BSA)} has been researched by fluorescence and electronic absorption spectroscopy. The results show that the complexes can bind via a moderate intercalation binding mode. According to the results obtained with both methods, the logKb and logKSV values of the complexes were found to be very close to each other. BSA quenching mechanism was found to be static. The results showed that the interaction between the complexes and BSA is driven by the hydrogen bond and van der Waals interaction. Additionally, the r values of the complexes (the complex 1 = 0.59 nm and the complex 2 = 0.53 nm) calculated from FRET theory suggested that the distance between the complexes (acceptor) and BSA (donor) is quite close. The complexes exhibited free radical scavenging activity compared to the standard antioxidant β‐carotene and catechin. Antiproliferative efficiency of the complexes on both breast cancer cells (MCF‐7 and MDA‐MB‐231) were also researched using the Sulforhodamine B (SRB) viability assay. It was found that the complex 1 (IC50 = 10.99 μM) exhibited higher cytotoxicity than cisplatin (IC50 = 15.6 μM) against MDA‐MB‐231 cell line. Additionally, intracellular reactive oxygen species (ROS) formation was determined by dihydroethidium (DHE) fluorescent staining. N‐acetylcysteine (NAC) was used as an efficient reactive oxygen species (ROS) scavenger. It was observed that newly synthesized Cu (II) complexes exhibited anti‐growth potential in human breast cancer cells. Additionally, it was determined that the complexes induced reactive oxygen species (ROS) formation in cells in a dose‐dependent manner.

Synthesis, Crystal Structure, Anticancer Activity and Interaction with Bovine Serum Albumin of Copper(II) Complex

Synthesis, crystal structure and anticancer activity of a novel ternary copper(II) complex with Schiff base derived from 2-amino-4-fluorobenzoic acid and salicylaldehyde

Synthesis and structure of a new tetracopper(II) complex with N -benzoate- N′ -[2-(2-hydroxyethylamino)ethyl]oxamide as bridging ligand: In vitro anticancer activities and DNA- and BSA-binding studies

Synthesis, Crystal Structure, Antibacterial Activity And Interaction With Bsa Of Copper(Ii) Complex With Ligand N,N '-Bis(4-Chlorobenzyl) Propane-1,2-Diamine

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Synthesis, Crystal Structure, Thermal Stability, Magnetic Property, and Biological Activity of a New Copper(II) Complex Based on 1,2,4-Benzenetricarboxylic Acid and 2,2 '-Bipyridine

Synthesis, Crystal Structure, DNA/bovine Serum Albumin Binding and Antitumor Activity of Two Transition Metal Complexes with 4‐acylpyrazolone Derivative

Synthesis and Crystal Structure of Binuclear Copper(II) Complex Bridged by N‐(2‐Hydroxyphenyl)‐N′‐[3‐(diethylamino)propyl]oxamide: in Vitro Anticancer Activity and Reactivity Toward DNA and Protein

Syntheses, Crystal Structure and Biological Evaluation of Three Novel Cu (II) Complexes with Schiff Base Derived from Fluorinated Amino Acid and Salicylaldehyde

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Synthesis and Crystal Structure of a New Copper(ii) Complex with N,N′-(4,4′-bithiazole-2,2′-diyl)diacetimidamide As Ligand: Molecular Docking, DNA-binding and Cytotoxicity Activity Studies

Mixed‐Ligand Mononuclear Copper(II) Complex: Crystal Structure and Anticancer Activity

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Synthesis and Crystal Structure of Bicopper(ii) Complexes: the Influence of Bridging Ligands on DNA/BSA Binding Behaviors and in Vitro Antitumor Activity

Synthesis and Structure of A Ternary Copper(Ii) Complex with Mixed Ligands of Diethylenetriamine and Picrate: Dna/Protein-Binding Property and in Vitro Anticancer Activity Studies

Synthesis, Crystal Structure, Biomolecular Interactions and Anticancer Properties of Ni(II), Cu(II) and Zn(II) Complexes Bearing S-allyldithiocarbazate

Synthesis, structure, and biological active evaluation of a new cyclic tetranuclear copper(II) complex bridged both by oxamido and carboxylate groups.

Structure and Biological Properties of Mixed-Ligand Cu(II) Schiff Base Complexes As Potential Anticancer Agents.

Copper (II) complexes based bis(pyrazolyl)borate derivatives as efficient anticancer agents: synthesis, characterization, X-ray structure, cytotoxicity, molecular docking and QSAR studies

Syntheses, crystal structures of copper (II)-based complexes of sulfonamide derivatives and their anticancer effects through the synergistic effect of anti-angiogenesis, anti-inflammation, pro-apoptosis and cuproptosis

New copper (II) complexes bearing tryptophan‐based Schiff bases and 2,2′‐bipyridine: Crystal structures, DNA/BSA interactions and antiproliferative activities